Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2020-05-12

Original market date: See footnote 1

2016-04-13

Product name:

ACT PROGESTERONE INJECTION

Description:

MULTI DOSE VIAL

DIN:

02446820 Electronic product monograph is not available

Company: 

TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada  M1B 2K9

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

68:32.00   PROGESTINS

Anatomical Therapeutic Chemical (ATC): See footnote 4

G03DA04  PROGESTERONE

Active ingredient group (AIG) number:See footnote 5

0106327001

List of active ingredient(s)
Active ingredient(s) Strength
PROGESTERONE 50 MG / ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: